Gamco Investors INC. ET AL Purchases 54,300 Shares of Anterix Inc. $ATEX

Key Points

• Gamco Investors Inc. increased its stake in Anterix Inc. by 36.6% in the first quarter, owning 202,570 shares valued at $7.41 million.
• Anterix reported an earnings per share of ($0.48), beating analysts' estimates of ($0.54) during its latest earnings release.
• The company has an average rating of "Strong Buy" from analysts, with a consensus target price of $67.00.

Gamco Investors INC. ET AL raised its position in Anterix Inc. (NASDAQ:ATEX - Free Report) by 36.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 202,570 shares of the company's stock after acquiring an additional 54,300 shares during the quarter. Gamco Investors INC. ET AL owned approximately 1.09% of Anterix worth $7,414,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. Nuveen LLC bought a new stake in shares of Anterix during the 1st quarter valued at about $7,204,000. Roubaix Capital LLC purchased a new position in Anterix in the first quarter worth about $5,918,000. Kettle Hill Capital Management LLC purchased a new position in Anterix in the fourth quarter worth about $2,353,000. Nuveen Asset Management LLC raised its holdings in Anterix by 26.4% in the fourth quarter. Nuveen Asset Management LLC now owns 185,573 shares of the company's stock worth $5,692,000 after buying an additional 38,770 shares during the last quarter. Finally, Barclays PLC raised its holdings in Anterix by 124.1% in the fourth quarter. Barclays PLC now owns 38,025 shares of the company's stock worth $1,166,000 after buying an additional 21,054 shares during the last quarter. Hedge funds and other institutional investors own 87.67% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen cut shares of Anterix from a "hold" rating to a "sell" rating in a report on Saturday, August 16th. One analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. Based on data from MarketBeat, Anterix currently has an average rating of "Strong Buy" and a consensus price target of $67.00.

Anterix Stock Performance

Shares of ATEX traded up $0.42 during mid-day trading on Monday, hitting $23.74. 225,720 shares of the company traded hands, compared to its average volume of 225,898. The stock has a 50-day moving average price of $23.23 and a two-hundred day moving average price of $29.39. Anterix Inc. has a 1 year low of $20.61 and a 1 year high of $42.91. The stock has a market cap of $444.89 million, a price-to-earnings ratio of 15.22 and a beta of 0.91.

Anterix (NASDAQ:ATEX - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.48) earnings per share for the quarter, beating the consensus estimate of ($0.54) by $0.06. Anterix had a net margin of 495.14% and a negative return on equity of 23.87%. The firm had revenue of $1.42 million during the quarter, compared to analysts' expectations of $1.51 million. On average, analysts forecast that Anterix Inc. will post -1.53 EPS for the current year.

Anterix Profile

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.